Telling a liberal that ObamaCare means rationing and death panels is akin to being a global warming denier or, worse yet, admitting you watch Sarah Palin’s outdoor show.Yet this week the FDA revoked its prior approval for the drug Avastin in treating breast cancer, despite pleas from patients, politicians and breast cancer groups, and clinical and anecdotal evidence of the drug’s effectiveness, the Wall Street Journal reports.Various studies have indicated Avastin improves survival rates and reduces tumor growth rates. The drug works by restricting blood flow to tumors, and is still approved for other forms of cancer. It can cost up to $90,000 per year.The problem is that once the FDA pulls its approval, Medicare will not cover the drug, and insurance companies may be reluctant at best to cover off-label use. Coincidentally, on the same day as the FDA announcement, a European regulator announced it would continue approval.The FDA claims “patients treated with Avastin did not live any longer than patients who were not treated with the drug,” and that there are serious side effects involved.The Washington Examiner quotes Sally Pipes, President of the Pacific Research Institute and a leading writer in the health care debate:Every year about 40,000 American women die from breast cancer. Avastin is the last hope for many not to meet that fate. While the drug is costly, it often provides immense benefits to patients.
here you go libs…. here’s your lauded govt. health care plan.